Therapeutic Strategies in Triple-Negative Breast Cancer.
作者信息
Paradiso Angelo, Singer Christian F
机构信息
Istituto Tumori 'Giovanni Paolo II', Istituto di Ricovero e Cura a Carattere Scientific, Bari, Italy.
Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.
出版信息
Breast Care (Basel). 2017 Mar;12(1):6-7. doi: 10.1159/000460238. Epub 2017 Feb 28.
Abstract
摘要
相似文献
1
Therapeutic Strategies in Triple-Negative Breast Cancer.三阴性乳腺癌的治疗策略
Breast Care (Basel). 2017 Mar;12(1):6-7. doi: 10.1159/000460238. Epub 2017 Feb 28.
2
Metabolic Reprogramming in Triple-Negative Breast Cancer.三阴性乳腺癌中的代谢重编程
Front Oncol. 2020 Mar 31;10:428. doi: 10.3389/fonc.2020.00428. eCollection 2020.
3
MicroRNAs as regulatory elements in triple negative breast cancer.微小RNA作为三阴性乳腺癌中的调控元件
Cancer Lett. 2014 Nov 1;354(1):1-4. doi: 10.1016/j.canlet.2014.07.036. Epub 2014 Aug 10.
4
Therapeutic Implications of the Molecular and Immune Landscape of Triple-Negative Breast Cancer.三阴性乳腺癌的分子和免疫格局的治疗意义
Pathol Oncol Res. 2018 Oct;24(4):701-716. doi: 10.1007/s12253-017-0307-2. Epub 2017 Sep 14.
5
Novel treatment approaches for triple-negative breast cancer.三阴性乳腺癌的新型治疗方法。
Clin Breast Cancer. 2010;10 Suppl 1:E16-22. doi: 10.3816/CBC.2010.s.003.
6
Directed therapy of subtypes of triple-negative breast cancer.三阴性乳腺癌亚型的定向治疗。
Oncologist. 2011;16 Suppl 1:71-8. doi: 10.1634/theoncologist.2011-S1-71.
7
Triple-negative breast cancer: risk factors to potential targets.三阴性乳腺癌：从风险因素到潜在靶点
Clin Cancer Res. 2008 Dec 15;14(24):8010-8. doi: 10.1158/1078-0432.CCR-08-1208.
8
Directed therapy of subtypes of triple-negative breast cancer.三阴性乳腺癌亚型的定向治疗。
Oncologist. 2010;15 Suppl 5:49-56. doi: 10.1634/theoncologist.2010-S5-49.
9
Molecular alterations in triple-negative breast cancer-the road to new treatment strategies.三阴性乳腺癌的分子改变——新治疗策略之路。
Lancet. 2017 Jun 17;389(10087):2430-2442. doi: 10.1016/S0140-6736(16)32454-0. Epub 2016 Dec 7.
10
The functional role of Notch signaling in triple-negative breast cancer.Notch 信号通路在三阴性乳腺癌中的功能作用。
Vitam Horm. 2013;93:277-306. doi: 10.1016/B978-0-12-416673-8.00013-7.
引用本文的文献
1
Anticancer effect of nor-wogonin (5, 7, 8-trihydroxyflavone) on human triple-negative breast cancer cells via downregulation of TAK1, NF-κB, and STAT3.柚皮素（5,7,8-三羟基黄酮）通过下调 TAK1、NF-κB 和 STAT3 对人三阴性乳腺癌细胞的抗癌作用。
Pharmacol Rep. 2019 Apr;71(2):289-298. doi: 10.1016/j.pharep.2019.01.001. Epub 2019 Jan 7.
2
extract (GLE) impairs breast cancer stem cells by targeting the STAT3 pathway.提取物（GLE）通过靶向STAT3信号通路损害乳腺癌干细胞。
Oncotarget. 2018 Nov 13;9(89):35907-35921. doi: 10.18632/oncotarget.26294.
本文引用的文献
1
Therapeutic Advances and New Directions for Triple-Negative Breast Cancer.三阴性乳腺癌的治疗进展与新方向
Breast Care (Basel). 2017 Mar;12(1):21-28. doi: 10.1159/000455821. Epub 2017 Feb 7.
2
Germline Mutations in Triple-Negative Breast Cancer.三阴性乳腺癌中的种系突变
Breast Care (Basel). 2017 Mar;12(1):15-19. doi: 10.1159/000455999. Epub 2017 Feb 24.
3
Biological Subtypes of Triple-Negative Breast Cancer.三阴性乳腺癌的生物学亚型
Breast Care (Basel). 2017 Mar;12(1):8-14. doi: 10.1159/000455820. Epub 2017 Feb 20.
4
Pathological complete response after cisplatin neoadjuvant therapy is associated with the downregulation of DNA repair genes in BRCA1-associated triple-negative breast cancers.顺铂新辅助治疗后的病理完全缓解与BRCA1相关三阴性乳腺癌中DNA修复基因的下调有关。
Oncotarget. 2016 Oct 18;7(42):68662-68673. doi: 10.18632/oncotarget.11900.
5
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease.三阴性乳腺癌：一种异质性疾病的挑战与机遇
Nat Rev Clin Oncol. 2016 Nov;13(11):674-690. doi: 10.1038/nrclinonc.2016.66. Epub 2016 May 17.
6
Triple negative breast cancer chemosensitivity and chemoresistance: current advances in biomarkers indentification.三阴性乳腺癌的化疗敏感性与化疗耐药性：生物标志物识别的当前进展
Expert Opin Ther Targets. 2016 Jun;20(6):705-20. doi: 10.1517/14728222.2016.1125469. Epub 2015 Dec 19.
7
Targeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease.三阴性乳腺癌的靶向治疗：攻克顽固疾病
Trends Pharmacol Sci. 2015 Dec;36(12):822-846. doi: 10.1016/j.tips.2015.08.009. Epub 2015 Nov 1.
Zotero 插件